The application of telemedicine in the field of oncology, involving the use of telecommunications technologies for remote cancer care, consultations, and support services.
A collaborative, multidisciplinary meeting conducted virtually through teleoncology platforms. Oncologists, radiologists, pathologists, and other specialists discuss and formulate comprehensive treatment plans for cancer patients.
The provision of oncology consultations through virtual means, allowing patients to connect with oncologists and receive expert advice on diagnosis, treatment options, and ongoing care without being physically present.
The use of telemedicine for remote pathology consultations in cancer diagnosis. Pathologists analyze digital pathology slides and collaborate with oncologists to determine the best course of action for patients.
The delivery of cancer treatment services remotely, including chemotherapy and radiation therapy. Teletherapy ensures that patients can receive essential treatments without the need for frequent hospital visits.
Continuous monitoring of cancer patients’ health status, symptoms, and treatment side effects using teleoncology platforms. This allows healthcare providers to intervene promptly and adjust treatment plans as needed.
The use of telemedicine to discuss and interpret genomic information related to cancer. Telegenomics enables remote consultations with genetic counselors and oncologists to guide personalized cancer treatment strategies.
Remote support services that help cancer patients navigate through their treatment journey. Teleoncology navigators assist with appointment scheduling, provide resources, and address patients’ concerns through virtual communication.
Customized plans created for cancer survivors that outline post-treatment care, follow-up appointments, and lifestyle recommendations. Teleoncology platforms facilitate the delivery and discussion of digital survivorship plans.